Business Context and Reporting Period
Company: AtriCure, Inc.
Filing Type: Form 8-K (Current Report)
Date of Report: July 20, 2006
Event: Announcement of FDA 510(k) clearance for the Isolator Transpolar Pen System and release of a new Isolator Transpolar open clamp.
Key Financial Metrics
This filing is a current report regarding regulatory approvals and product announcements. It does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics.
Material Changes
- Regulatory Approval: Received FDA 510(k) clearance for the Isolator Transpolar Pen System for pacing, sensing, stimulating, and recording during the evaluation of cardiac arrhythmias.
- Product Expansion: The new clearance expands the device's utility beyond its previously cleared use for the ablation of cardiac tissues.
- New Product Launch: Announced the release of a new Isolator Transpolar open clamp.
Guidance, Outlook, and Risks
The filing does not provide financial guidance, management commentary on future performance, specific risk factors, or contingencies. The document focuses solely on the regulatory milestone and product availability.
Investor Verification Checklist
- Verify the specific clinical indications covered by the new FDA 510(k) clearance for the Isolator Transpolar Pen System.
- Confirm the commercial availability timeline for the new Isolator Transpolar open clamp.
- Review the full text of the press release (Exhibit 99.1) for details on market impact or sales strategy not included in the 8-K summary.